Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Aspen Aerogels
ASPN
$485M
| $4.54M | ﹤0.01% |
690,751
+56,600
| +9% | +$363K |
|
|
AMNB
1702
DELISTED
American National Bankshares Inc
AMNB
| $4.54M | ﹤0.01% |
181,500
-12,900
| -7% | -$309K |
|
1703
Miller Industries
MLR
$645M
| $4.54M | ﹤0.01% |
152,400
+73,700
| +94% | +$2.1M |
|
1704
W&T Offshore
WTI
$554M
| $4.54M | ﹤0.01% |
1,989,950
-5,253,660
| -73% | -$13.3M |
|
|
SILK
1705
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.54M | ﹤0.01% |
108,300
+90,200
| +498% | +$3.46M |
|
1706
Information Services Group
III
$250M
| $4.54M | ﹤0.01% |
2,191,454
+3,700
| +0.2% | +$7.94K |
|
1707
La-Z-Boy
LZB
$1.67B
| $4.53M | ﹤0.01% |
167,500
+123,200
| +278% | +$2.96M |
|
|
LX
1708
LexinFintech Holdings
LX
$224M
| $4.53M | ﹤0.01% |
425,901
-431,400
| -50% | -$3.84M |
|
1709
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $4.52M | ﹤0.01% |
86,600
+54,600
| +171% | +$2.57M |
|
1710
Parsons
PSN
$5.12B
| $4.51M | ﹤0.01% |
124,500
+84,500
| +211% | +$3.18M |
|
1711
Veru
VERU
$46.5M
| $4.49M | ﹤0.01% |
134,369
+18,810
| +16% | +$647K |
|
1712
Performance Food Group
PFGC
$16.8B
| $4.49M | ﹤0.01% |
+153,900
| New | +$4M |
|
|
SF
1713
Stifel
SF
$12.9B
| $4.48M | ﹤0.01% |
212,573
+127,125
| +149% | +$2.55M |
|
|
RCM
1714
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.48M | ﹤0.01% |
+401,598
| New | +$4.13M |
|
|
SMMF
1715
DELISTED
Summit Financial Group, Inc.
SMMF
| $4.48M | ﹤0.01% |
271,635
-9,200
| -3% | -$151K |
|
|
WWE
1716
DELISTED
World Wrestling Entertainment
WWE
| $4.47M | ﹤0.01% |
103,000
+21,600
| +27% | +$927K |
|
|
SMED
1717
DELISTED
Sharps Compliance Corp
SMED
| $4.47M | ﹤0.01% |
635,746
+105,000
| +20% | +$747K |
|
1718
Spero Therapeutics
SPRO
$71.2M
| $4.46M | ﹤0.01% |
329,903
+5,600
| +2% | +$62.9K |
|
|
GFN
1719
DELISTED
General Finance Corporation
GFN
| $4.46M | ﹤0.01% |
664,240
-30,600
| -4% | -$186K |
|
|
LL
1720
DELISTED
LL Flooring Holdings, Inc.
LL
| $4.44M | ﹤0.01% |
320,500
+160,700
| +101% | +$1.36M |
|
1721
abrdn Physical Gold Shares ETF
SGOL
$7.47B
| $4.43M | ﹤0.01% |
+258,700
| New | +$4.27M |
|
1722
Gogo Inc
GOGO
$383M
| $4.43M | ﹤0.01% |
1,401,200
-372,200
| -21% | -$800K |
|
1723
St. Joe Company
JOE
$3.89B
| $4.42M | ﹤0.01% |
227,600
-126,000
| -36% | -$2.32M |
|
1724
Mastech Digital
MHH
$94.7M
| $4.42M | ﹤0.01% |
170,370
+70,195
| +70% | +$1.24M |
|
|
TCDA
1725
DELISTED
Tricida, Inc. Common Stock
TCDA
| $4.42M | ﹤0.01% |
160,717
+42,917
| +36% | +$1.17M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.